Skip to main content

Journal of Hematology & Oncology

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Collections open for submissions

Deepak Sethi / Getty Images / iStock.

Deepak Sethi / Getty Images / iStock.

First-in-human clinical trials for cancer and blood disorders

This series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.

The deadline for submissions is 31 October 2021.

How we treat image

xixinxing / Fotolia.

How we treat

This series will focus on guidelines, consensus, and multidisciplinary approaches on cancers and blood disorders. All submissions to this series should be either invited or pre-approved. Prospective authors should contact the Journal Development Manager for pre-approval at aoife.buckley@springernature.com. The deadline for submissions is 31 October 2021.

weyo / stock.adobe.com

weyo / stock.adobe.com

New developments in delivery technology, materials, and molecular engineering for drug discovery

This series covers new technology, materials, and models for drug discovery. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus. The deadline for submissions is 31 October 2021.

Thematic series

We are pleased to present two recent Journal of Hematology & Oncology thematic series:

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Articles

  5. Authors: Mathieu Simonin, Aline Schmidt, Christophe Bontoux, Marie-Émilie Dourthe, Etienne Lengliné, Guillaume P. Andrieu, Ludovic Lhermitte, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Isabelle Arnoux, Stéphane Ducassou, Elizabeth Macintyre, Virginie Gandemer, Hervé Dombret…

    Content type: Rapid communication

Most recent articles RSS

View all articles

Most accessed articles RSS

View all articles

CAHON: Stop hate crimes and racism

The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond. 

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

JHO logo
Submit manuscript

Follow

Annual Journal Metrics

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us